Skip navigation Wisconsin State Legislature
Up
Chapter NR 665
Appendix VI
COMPOUNDS WITH HENRY’S LAW CONSTANT LESS THAN 0.1 Y/X
 
Compound name
CAS No.
Acetaldol . . . . . . . . . . . . . . . . . . . . .
107−89−1
Acetamide . . . . . . . . . . . . . . . . . . . . .
60−35−5
2−Acetylaminofluorene . . . . . . . . . .
53−96−3
3−Acetyl−5−hydroxypiperidine.
3−Acetylpiperidine . . . . . . . . . . . . . .
618−42−8
1−Acetyl−2−thiourea . . . . . . . . . . . .
591−08−2
Acrylamide . . . . . . . . . . . . . . . . . . . .
79−06−1
Acrylic acid . . . . . . . . . . . . . . . . . . .
79−10−7
Adenine . . . . . . . . . . . . . . . . . . . . . .
73−24−5
Adipic acid . . . . . . . . . . . . . . . . . . . .
124−04−9
Adiponitrile . . . . . . . . . . . . . . . . . . .
111−69−3
Alachlor . . . . . . . . . . . . . . . . . . . . . .
15972−60−8
Aldicarb . . . . . . . . . . . . . . . . . . . . . .
116−06−3
Ametryn . . . . . . . . . . . . . . . . . . . . . .
834−12−8
4−Aminobiphenyl . . . . . . . . . . . . . . .
92−67−1
4−Aminopyridine . . . . . . . . . . . . . . .
504−24−5
Aniline . . . . . . . . . . . . . . . . . . . . . . .
62−53−3
o−Anisidine . . . . . . . . . . . . . . . . . . .
90−04−0
Anthraquinone . . . . . . . . . . . . . . . . .
84−65−1
Atrazine . . . . . . . . . . . . . . . . . . . . . .
1912−24−9
Benzenearsonic acid . . . . . . . . . . . . .
98−05−5
Benzenesulfonic acid . . . . . . . . . . . .
98−11−3
Benzidine . . . . . . . . . . . . . . . . . . . . .
92−87−5
Benzo(a)anthracene . . . . . . . . . . . . .
56−55−3
Benzo(k)fluoranthene . . . . . . . . . . . .
207−08−9
Benzoic acid . . . . . . . . . . . . . . . . . . .
65−85−0
Benzo(g,h,i)perylene . . . . . . . . . . . .
191−24−2
Benzo(a)pyrene . . . . . . . . . . . . . . . .
50−32−8
Benzyl alcohol . . . . . . . . . . . . . . . . .
100−51−6
gamma−BHC . . . . . . . . . . . . . . . . . .
58−89−9
Bis(2−ethylhexyl)phthalate . . . . . . .
117−81−7
Bromochloromethyl acetate.
Bromoxynil . . . . . . . . . . . . . . . . . . . .
1689−84−5
Butyric acid . . . . . . . . . . . . . . . . . . .
107−92−6
Caprolactam (hexahydro−2H−aze-
105−60−2
pin−2−one) . . . . . . . . . . . . . . . . . . . .
Catechol (o−dihydroxybenzene) . . . .
120−80−9
Cellulose . . . . . . . . . . . . . . . . . . . . . .
9004−34−6
Cell wall.
Chlorhydrin (3−Chloro−1,2−propan-
96−24−2
ediol) . . . . . . . . . . . . . . . . . . . . . . . . .
Chloroacetic acid . . . . . . . . . . . . . . .
79−11−8
2−Chloroacetophenone . . . . . . . . . . .
93−76−5
p−Chloroaniline . . . . . . . . . . . . . . . .
106−47−8
p−Chlorobenzophenone . . . . . . . . . .
134−85−0
Chlorobenzilate . . . . . . . . . . . . . . . .
510−15−6
p−Chloro−m−cresol (6−chloro−m−
59−50−7
cresol) . . . . . . . . . . . . . . . . . . . . . . . .
3−Chloro−2,5−diketopyrrolidine.
Chloro−1,2−ethane diol.
4−Chlorophenol . . . . . . . . . . . . . . . .
106−48−9
Chlorophenol polymers (2−chloro-
95−57−8 &
phenol & 4−chlorophenol) . . . . . . . .
106−48−9
1−(o−Chlorophenyl)thiourea . . . . . .
5344−82−1
Chrysene . . . . . . . . . . . . . . . . . . . . . .
218−01−9
Citric acid . . . . . . . . . . . . . . . . . . . . .
77−92−9
Creosote . . . . . . . . . . . . . . . . . . . . . .
8001−58−9
m−Cresol . . . . . . . . . . . . . . . . . . . . .
108−39−4
o−Cresol . . . . . . . . . . . . . . . . . . . . . .
95−48−7
p−Cresol . . . . . . . . . . . . . . . . . . . . . .
106−44−5
Cresol (mixed isomers) . . . . . . . . . .
1319−77−3
4−Cumylphenol . . . . . . . . . . . . . . . .
27576−86−9
Cyanide . . . . . . . . . . . . . . . . . . . . . . .
57−12−5
4−Cyanomethyl benzoate.
Diazinon . . . . . . . . . . . . . . . . . . . . . .
333−41−5
Dibenzo(a,h)anthracene . . . . . . . . . .
53−70−3
Dibutylphthalate . . . . . . . . . . . . . . . .
84−74−2
2,5−Dichloroaniline (N,N’−dichloro-
95−82−9
aniline) . . . . . . . . . . . . . . . . . . . . . . .
2,6−Dichlorobenzonitrile11 . . . . . . .
1194−65−6
2,6−Dichloro−4−nitroaniline . . . . . .
99−30−9
2,5−Dichlorophenol . . . . . . . . . . . . .
333−41−5
3,4−Dichlorotetrahydrofuran.
Dichlorvos (DDVP) . . . . . . . . . . . . .
62−73−7
Diethanolamine . . . . . . . . . . . . . . . .
111−42−2
N,N−Diethylaniline . . . . . . . . . . . . .
91−66−7
Diethylene glycol . . . . . . . . . . . . . . .
111−46−6
Diethylene glycol dimethyl ether
111−96−6
(dimethyl Carbitol) . . . . . . . . . . . . . .
Diethylene glycol monobutyl ether
112−34−5
(butyl Carbitol) . . . . . . . . . . . . . . . . .
Diethylene glycol monoethyl ether
112−15−2
acetate (Carbitol acetate) . . . . . . . . .
Diethylene glycol monoethyl ether
111−90−0
(Carbitol Cellosolve) . . . . . . . . . . . .
Diethylene glycol monomethyl ether
111−77−3
(methyl Carbitol) . . . . . . . . . . . . . . .
N,N’−Diethylhydrazine . . . . . . . . . .
1615−80−1
Diethyl (4−methylumbelliferyl) thio-
299−45−6
nophosphate . . . . . . . . . . . . . . . . . . .
Diethyl phosphorothioate . . . . . . . . .
126−75−0
N,N’−Diethylpropionamide . . . . . . .
15299−99−7
Dimethoate . . . . . . . . . . . . . . . . . . . .
60−51−5
2,3−Dimethoxystrychnidin−10−one .
357−57−3
4−Dimethylaminoazobenzene . . . . .
60−11−7
7,12−Dimethylbenz(a)anthracene . . .
57−97−6
3,3−Dimethylbenzidine . . . . . . . . . .
119−93−7
Dimethylcarbamoyl chloride . . . . . .
79−44−7
Dimethyldisulfide . . . . . . . . . . . . . . .
624−92−0
Dimethylformamide . . . . . . . . . . . . .
68−12−2
1,1−Dimethylhydrazine . . . . . . . . . .
57−14−7
Dimethylphthalate . . . . . . . . . . . . . .
131−11−3
Dimethylsulfone . . . . . . . . . . . . . . . .
67−71−0
Dimethylsulfoxide . . . . . . . . . . . . . .
67−68−5
4,6−Dinitro−o−cresol . . . . . . . . . . . .
534−52−1
1,2−Diphenylhydrazine . . . . . . . . . .
122−66−7
Dipropylene glycol
110−98−5
(1,1’−oxydi−2−propanol) . . . . . . . . .
Endrin . . . . . . . . . . . . . . . . . . . . . . . .
72−20−8
Epinephrine . . . . . . . . . . . . . . . . . . .
51−43−4
mono−Ethanolamine . . . . . . . . . . . . .
141−43−5
Ethyl carbamate (urethane) . . . . . . .
51−79−6
Ethylene glycol . . . . . . . . . . . . . . . . .
107−21−1
Ethylene glycol monobutyl ether
111−76−2
(butyl Cellosolve) . . . . . . . . . . . . . . .
Ethylene glycol monoethyl ether
110−80−5
(Cellosolve) . . . . . . . . . . . . . . . . . . .
Ethylene glycol monoethyl ether ace-
111−15−9
tate (Cellosolve acetate) . . . . . . . . . .
Ethylene glycol monomethyl ether
109−86−4
(methyl Cellosolve) . . . . . . . . . . . . .
Ethylene glycol monophenyl ether
122−99−6
(phenyl Cellosolve) . . . . . . . . . . . . .
Ethylene glycol monopropyl ether
2807−30−9
(propyl Cellosolve) . . . . . . . . . . . . . .
Ethylene thiourea (2−imidazolidine-
96−45−7
thione) . . . . . . . . . . . . . . . . . . . . . . . .
4−Ethylmorpholine . . . . . . . . . . . . . .
100−74−3
3−Ethylphenol . . . . . . . . . . . . . . . . .
620−17−7
Fluoroacetic acid, sodium salt . . . . .
62−74−8
Formaldehyde . . . . . . . . . . . . . . . . . .
50−00−0
Formamide . . . . . . . . . . . . . . . . . . . .
75−12−7
Formic acid . . . . . . . . . . . . . . . . . . . .
64−18−6
Fumaric acid . . . . . . . . . . . . . . . . . . .
110−17−8
Glutaric acid . . . . . . . . . . . . . . . . . . .
110−94−1
Glycerin (Glycerol) . . . . . . . . . . . . .
56−81−5
Glycidol . . . . . . . . . . . . . . . . . . . . . .
556−52−5
Glycinamide . . . . . . . . . . . . . . . . . . .
598−41−4
Glyphosate . . . . . . . . . . . . . . . . . . . .
1071−83−6
Guthion . . . . . . . . . . . . . . . . . . . . . . .
86−50−0
Hexamethylene−1,6−diisocyanate
822−06−0
(1,6−diisocyanatohexane) . . . . . . . . .
Hexamethyl phosphoramide . . . . . . .
680−31−9
Hexanoic acid . . . . . . . . . . . . . . . . . .
142−62−1
Hydrazine . . . . . . . . . . . . . . . . . . . . .
302−01−2
Hydrocyanic acid . . . . . . . . . . . . . . .
74−90−8
Hydroquinone . . . . . . . . . . . . . . . . . .
123−31−9
Hydroxy−2−propionitrile (hydracry-
109−78−4
lonitrile) . . . . . . . . . . . . . . . . . . . . . .
Indeno (1,2,3−cd) pyrene . . . . . . . . .
193−39−5
Lead acetate . . . . . . . . . . . . . . . . . . .
301−04−2
Lead subacetate (lead acetate, mono-
1335−32−6
basic) . . . . . . . . . . . . . . . . . . . . . . . .
Leucine . . . . . . . . . . . . . . . . . . . . . . .
61−90−5
Malathion . . . . . . . . . . . . . . . . . . . . .
121−75−5
Maleic acid . . . . . . . . . . . . . . . . . . . .
110−16−7
Maleic anhydride . . . . . . . . . . . . . . .
108−31−6
Mesityl oxide . . . . . . . . . . . . . . . . . .
141−79−7
Methane sulfonic acid . . . . . . . . . . .
75−75−2
Methomyl . . . . . . . . . . . . . . . . . . . . .
16752−77−5
p−Methoxyphenol . . . . . . . . . . . . . . .
150−76−5
Methyl acrylate . . . . . . . . . . . . . . . . .
96−33−3
4,4’−Methylene−bis−(2−chloroani-
101−14−4
line) . . . . . . . . . . . . . . . . . . . . . . . . . .
4,4’−Methylenediphenyl diisocya-
101−68−8
nate (diphenyl methane diisocyanate)
4,4’−Methylenedianiline . . . . . . . . . .
101−77−9
Methylene diphenylamine (MDA).
5−Methylfurfural . . . . . . . . . . . . . . .
620−02−0
Methylhydrazine . . . . . . . . . . . . . . . .
60−34−4
Methyliminoacetic acid.
Methyl methane sulfonate . . . . . . . .
66−27−3
1−Methyl−2−methoxyaziridine.
Methylparathion . . . . . . . . . . . . . . . .
298−00−0
Methyl sulfuric acid (sulfuric acid,
77−78−1
dimethyl ester) . . . . . . . . . . . . . . . . .
4−Methylthiophenol . . . . . . . . . . . . .
106−45−6
Monomethylformamide (N−methyl-
123−39−7
formamide) . . . . . . . . . . . . . . . . . . . .
Nabam . . . . . . . . . . . . . . . . . . . . . . .
142−59−6
alpha−Naphthol . . . . . . . . . . . . . . . .
90−15−3
beta−Naphthol . . . . . . . . . . . . . . . . .
135−19−3
alpha−Naphthylamine . . . . . . . . . . . .
134−32−7
beta−Naphthylamine . . . . . . . . . . . . .
91−59−8
Neopentyl glycol (dimethylolpro-
126−30−7
panedimethylpropane) . . . . . . . . . . . . . . . . . . . . . . . . .
Niacinamide . . . . . . . . . . . . . . . . . . .
98−92−0
o−Nitroaniline . . . . . . . . . . . . . . . . . .
88−74−4
Nitroglycerin . . . . . . . . . . . . . . . . . .
55−63−0
2−Nitrophenol . . . . . . . . . . . . . . . . . .
88−75−5
4−Nitrophenol . . . . . . . . . . . . . . . . . .
100−02−7
N−Nitrosodimethylamine . . . . . . . . .
62−75−9
Nitrosoguanidine . . . . . . . . . . . . . . .
674−81−7
N−Nitroso−n−methylurea . . . . . . . . .
684−93−5
N−Nitrosomorpholine (4−nitroso-
59−89−2
morpholine) . . . . . . . . . . . . . . . . . . .
Oxalic acid . . . . . . . . . . . . . . . . . . . .
144−62−7
Parathion . . . . . . . . . . . . . . . . . . . . . .
56−38−2
Pentaerythritol . . . . . . . . . . . . . . . . .
115−77−5
Phenacetin . . . . . . . . . . . . . . . . . . . .
62−44−2
Phenol . . . . . . . . . . . . . . . . . . . . . . . .
108−95−2
Phenylacetic acid . . . . . . . . . . . . . . .
103−82−2
m−Phenylene diamine . . . . . . . . . . .
108−45−2
o−Phenylene diamine . . . . . . . . . . . .
95−54−5
p−Phenylene diamine . . . . . . . . . . . .
106−50−3
Phenyl mercuric acetate . . . . . . . . . .
62−38−4
Phorate . . . . . . . . . . . . . . . . . . . . . . .
298−02−2
Phthalic anhydride . . . . . . . . . . . . . .
85−44−9
alpha−Picoline (2−methyl pyridine) .
109−06−8
1,3−Propane sulfonesultone. . . . . . . . . . . . .
1120−71−4
beta−Propiolactone . . . . . . . . . . . . . .
57−57−8
Propoxur (Baygon) . . . . . . . . . . . . . .
114−26−1
Propylene glycol . . . . . . . . . . . . . . . .
57−55−6
Pyrene . . . . . . . . . . . . . . . . . . . . . . . .
129−00−0
Pyridinium bromide . . . . . . . . . . . . .
39416−48−3
Quinoline . . . . . . . . . . . . . . . . . . . . .
91−22−5
Quinone (p−benzoquinone) . . . . . . .
106−51−4
Resorcinol . . . . . . . . . . . . . . . . . . . . .
108−46−3
Simazine . . . . . . . . . . . . . . . . . . . . . .
122−34−9
Sodium acetate . . . . . . . . . . . . . . . . .
127−09−3
Sodium formate . . . . . . . . . . . . . . . .
141−53−7
Strychnine . . . . . . . . . . . . . . . . . . . . .
57−24−9
Succinic acid . . . . . . . . . . . . . . . . . . .
110−15−6
Succinimide . . . . . . . . . . . . . . . . . . .
123−56−8
Sulfanilic acid . . . . . . . . . . . . . . . . . .
121−47−1
Terephthalic acid . . . . . . . . . . . . . . .
100−21−0
Tetraethyldithiopyrophosphate . . . . .
3689−24−5
Tetraethylenepentamine . . . . . . . . . .
112−57−2
Thiofanox . . . . . . . . . . . . . . . . . . . . .
39196−18−4
Thiosemicarbazide . . . . . . . . . . . . . .
79−19−6
2,4−Toluenediamine . . . . . . . . . . . . .
95−80−7
2,6−Toluenediamine . . . . . . . . . . . . .
823−40−5
3,4−Toluenediamine . . . . . . . . . . . . .
496−72−0
2,4−Toluene diisocyanate . . . . . . . . .
584−84−9
p−Toluic acid . . . . . . . . . . . . . . . . . .
99−94−5
m−Toluidine . . . . . . . . . . . . . . . . . . .
108−44−1
1,1,2−Trichloro−1,2,2−trifluoroeth-
76−13−1
ane . . . . . . . . . . . . . . . . . . . . . . . . . .
Triethanolamine . . . . . . . . . . . . . . . .
102−71−6
Triethylene glycol dimethyl ether . . .
112−49−2
Tripropylene glycol . . . . . . . . . . . . .
24800−44−0
Warfarin . . . . . . . . . . . . . . . . . . . . . .
81−81−2
3,4−Xylenol (3,4−dimethylphenol) .
95−65−8
 
 
69Section 69   NR 666.100 (2) (a), (3) (c), and (4) (c) 1. a. are amended to read:
NR 666.100 (2) (a) Except as provided by under pars. (b), (c), and (d), the standards of this subchapter do not apply to a new hazardous waste boiler or industrial furnace unit that becomes subject to hazardous waste license requirements after October 12, 2005; or no longer apply when an affected source owner or operator of an existing hazardous waste boiler or industrial furnace unit demonstrates compliance with the maximum achievable control technology (MACT) requirements of under 40 CFR part 63, subpart EEE, by conducting a comprehensive performance test and submitting to the department a notification of compliance under 40 CFR 63.1207(j) and 63.1210(d) documenting compliance with 40 CFR part 63, subpart EEE. Nevertheless, even after this demonstration of compliance with the MACT standards, hazardous waste license conditions that were based on the standards of this chapter shall continue to be in effect until the conditions are removed from the license or the license is terminated or revoked, unless the license expressly provides otherwise.
(3) (c) Hazardous wastes that are exempt from regulation under ss. NR 661.0004 and 661.0006 (1) (c) 3. and 4., and hazardous wastes that are subject to the special requirements conditions for exemption for very small quantity generators under ss. NR 662.013 and 662.014.
(4) (c) 1. a. A waste listed in ch. NR 666 Appendix IX under ch. NR 666 Appendix XI shall contain recoverable levels of lead, a waste listed in under ch. NR 666 Appendix XII shall contain recoverable levels of nickel or chromium, a waste listed in under ch. NR 666 Appendix XIII shall contain recoverable levels of mercury and contain less than 500 ppm of ch. NR 661 Appendix VIII organic constituents, and baghouse bags used to capture metallic dusts emitted by steel manufacturing shall contain recoverable levels of metal.
70Section 70   NR 666.102 (1) (b) 6., (5) (c) 1. e., (5) (f) 2. b. 2), and (5) (h) 3. are amended to read:
NR 666.102 (1) (b) 6. In Under subch. F of ch. NR 664 (Corrective Action) (Releases from Solid Waste Management Units, Monitoring, and Corrective Action), ss. NR 664.0090 and 664.0101.
(5) (c) 1. e. Such other Other operating requirements as are necessary to ensure that the particulate standard in s. NR 666.111 (2) under s. NR 666.105 (1) is met.
(5) (f) 2. b. 2) The rolling average for the selected averaging period is defined as the arithmetic mean of one hour block averages for the averaging period. A one hour one-hour block average is the arithmetic mean of the one minute one-minute averages recorded during the 60-minute period beginning at one minute after the beginning of the preceding clock hour.
(5) (h) 3. The boiler or industrial furnace and associated equipment (pumps, values valves, pipes, fuel storage tanks, etc.) shall be subjected to thorough visual inspection when it contains hazardous waste, at least daily for leaks, spills, fugitive emissions, and signs of tampering.
71Section 71   NR 666.103 (2) (b) 5. b. 2), (e) 2. a., (3) (a) 1., 9. (intro) and a., (d) 4. c. 1), and (7) (a) 1. are amended to read:
NR 666.103 (2) (b) 5. b. 2) Source of meterological meteorological data.
(e) 2. a. The feed rate of each metal shall be limited at any time to 10 times the feed rate that would be allowed on a an hourly rolling average basis.
(3) (a) 1. Feed rate of total hazardous waste and (, unless complying with the Tier I or adjusted Tier I metals feed rate screening limits under s. NR 666.106 (2) or (5) and the total chlorine and chloride feed rate screening limits under s. NR 666.107 (2) or (5)), pumpable hazardous waste.
9. For systems using wet scrubbers, including wet ionizing scrubbers (unless complying with Tier I or adjusted Tier I metals feed rate screening limits under s. NR 666.106 (2) (a) or (5)) and the total chlorine and chloride feed rate screening limits under s. NR 666.107 (2) (a) or (5):
a. Minimum liquid to flue gas ration ratio.
(d) 4. c. 1) The feed rate of each metal shall be limited at any time to 10 times the feed rate that would be allowed on a an hourly rolling average basis.
(7) (a) 1. If compliance with the combustion chamber temperature limit is based on a an hourly rolling average, the minimum temperature during the compliance test is considered to be the average over all runs of the lowest hourly rolling average for each run.
72Section 72   NR 666.106 (4) (a) is amended to read:
NR 666.106 (4) (a) General. Conformance with the Tier III metals controls shall be demonstrated by emissions testing to determine the emission rate for each the metal. In addition, conformance with either the Tier III or adjusted Tier I metals controls shall be demonstrated by air dispersion modeling to predict the maximum annual average off-site ground level concentration for each dispersion modeling to predict the maximum annual average off-site ground level concentration for each the metal, and a demonstration that acceptable ambient levels are not exceeded.
73Section 73   NR 666.109 (2) (intro.) is amended to read:
NR 666.109 (2) Waiver of particular particulate matter standard. The particulate matter standard of under s. NR 666.105 does not apply if both of the following conditions are met:
74Section 74   NR 666.502 (8) (intro.) and (9) (b) 2. a. (intro.) are amended to read:
NR 666.502 (8)  Procedures for healthcare facilities for managing rejected shipments of non-creditable hazardous waste pharmaceuticals. A healthcare facility that sends a shipment of non-creditable hazardous waste pharmaceuticals to a designated facility with the understanding that the designated facility can accept and manage the waste, and later receives that shipment back as a rejected load in accordance with the manifest discrepancy provisions under s. NR 664.0072 or 665.0072 may accumulate the returned rejected non-creditable hazardous waste pharmaceuticals on-site for up to an additional 90 calendar days provided the rejected or returned shipment is managed in accordance with subs. (4) and (5). Upon receipt of the returned rejected shipment, the healthcare facility shall do all of the following:
(9) (b) 2. a. If a healthcare facility does not receive a copy of the manifest for a rejected shipment of the non-creditable hazardous waste pharmaceuticals that is forwarded by the designated facility to an alternate facility using appropriate manifest procedures, with the signature of the owner or operator of the alternate facility, within 60 calendar days of the date the non-creditable hazardous waste was accepted by the initial transporter forwarding the shipment of non-creditable hazardous waste pharmaceuticals from the designated facility to the alternate facilit y facility, the healthcare facility shall submit all of the following to the department:
75Section 75   NR 666.504 (2) (intro.) and (a) are amended to read:
NR 666.504 (2) Off-site collection of hazardous waste pharmaceuticals generated by a healthcare facility that is a very small quantity generator. A healthcare facility that is a very small quantity generator for both hazardous waste pharmaceuticals and non-pharmaceutical hazardous waste may send its hazardous waste pharmaceuticals off-site off site to another healthcare facility generator, provided one of the following is met:
(a) The receiving healthcare facility meets the conditions specified in under ss. NR 666.502 (a) NR 666.502 (12) and 666.503 (2), as applicable.
76Section 76   NR 666.505 is amended to read:
NR 666.505 Prohibition of sewering hazardous waste pharmaceuticals. All healthcare facilities, including very small quantity generators operating under s. NR 662.014 in lieu of this subchapter, and reverse distributors are prohibited from discharging hazardous waste pharmaceuticals to a sewer system that passes through to a publicly-owned treatment works. Healthcare facilities and reverse distributors remain subject to the prohibitions in 40 CFR 403.5 (b) (1).
77Section 77   NR 666.506 (2) (c) (intro.) is amended to read:
NR 666.506 (2) (c) Destr oyed Destroyed by a method that the drug enforcement administration has publicly deemed in writing to meet its non-retrievable standard of destruction or combusted at one of the following:
78Section 78   NR 666.507 (2) is amended to read:
NR 666.507 (2) Syringes. A syringe is considered empty and the residues are not regulated as hazardous waste under this subchapter provided the contents have been removed by fully depressing the plunger of the syringe. If a syringe is not empty, the s yringe syringe shall be placed with its remaining hazardous waste pharmaceuticals into a container that is managed and disposed of as a non-creditable hazardous waste pharmaceutical under this subchapter and any the applicable federal, state, and local requirements for sharps containers and medical waste.
79Section 79   NR 666.510 (3) (d) 5. (intro.) is amended to read:
NR 666.510 (3) (d) 5. Manage a ny any container of ignitable or reactive evaluated hazardous waste pharmaceuticals, or any container of commingled incompatible evaluated hazardous waste pharmaceuticals so that the container does not have the potential to do any of the following:
_Hlk147406769Section 80   NR 666.903 (3) (a) and (7) (c) are amended to read:
NR 666.903 (3) (a) Label each the container with either the words “hazardous waste" or other words that identify the contents of the container and an indication of the hazards of the contents.
(7) (c) Portable fire extinguishers, fire control equipment (including special extinguishing equipment, such as that using foam, inert gas, or dry chemicals), and spill control equipment when required.
81Section 81   NR 666.904 (2) (a) is amended to read:
NR 666.904 (2) (a) Label each the container with either the words “hazardous waste" or other words that identify the contents of the container and an indication of the hazards of the contents.
82Section 82   NR 666.904 (2) (f) is created to read:
NR 666.904 (2) (f) Make an accurate waste determination according to s. NR 662.011.
_Hlk147409123Section 83   NR 666.904 (5) (c) is amended to read:
NR 666.904 (5) (c) In the event of a fire, explosion, or other release which that could threaten human health or if a spill has reached surface water, immediately notify the national response center, using their its 24-hour toll free number (800)424-8802(800) 424-8802. The notification shall include all of the following information: The name and address of the facility owner, date, time and type of incident, quantity and type of hazardous waste involved in the incident, extent of injuries, if any and estimated quantity and disposition of recovered materials, if any.
84Section 84   NR 666.905 (intro.) is amended to read:
NR 666.905 Transportation requirements. An owner or operator of a collection facility shall ensure delivery of all the hazardous waste to a licensed hazardous waste treatment, storage or disposal facility, legitimate recycling facility under s. NR 660.43, or permanent collection facility, according to the following:
_Hlk153548029Section 85   NR 666.905 (1) (f) is repealed and recreated to read:
NR 666.905 (1) (f) Do all of the following:
1. Use a manifest that consists of at least the number of copies that will provide the collection facility owner or operator, each transporter, the owner or operator of the designated facility, and the department with one copy each for their records and another final, signed copy to be returned to the collection facility owner or operator.
2. Prepare and use a manifest, OMB control number 2050-0039, on EPA Form 8700-22, and if necessary, EPA Form 8700–22A, according to the instructions in the appendix to 40 CFR part 262.
3. Keep a copy of each manifest signed by the collection facility owner or operator and the initial transporter for 3 years or until the facility owner or operator receives a signed copy from the designated hazardous waste facility that received the waste.
4. Retain the final, signed copy of the manifest as a record for at least 3 years from the date the waste was accepted by the initial transporter.
_Hlk153548138Section 86   NR 666.905 (3) (c) is amended to read:
NR 666.905 (3) (c): Under 49 CFR 171.1 (d) (5), governmental employees who self-transport hazardous materials or hazardous waste are exempt from the DOT hazardous materials requirements (including packaging, labeling, marking, placarding, and manifesting) if the transportation is done solely for non-commercial, governmental purposes.
Section 87.   NR 666 Appendix IV Table is amended to read:
Chapter NR 666
APPENDIX IV
REFERENCE AIR CONCENTRATIONS*
Constituent
CAS No.
RAC (ug/m3)
Acetaldehyde
75−07−0
10
Acetonitrile
75−05−8
10
Acetophenone
98−86−2
100
Acrolein
107−02−8
20
Aldicarb
116−06−3
1
Aluminum Phosphide
20859−73−8
0.3
Allyl Alcohol
107−18−6
5
Antimony
7440−36−0
0.3
Barium
7440−39−3
50
Barium Cyanide
542−62−1
50
Bromomethane
74−83−9
0.8
Calcium Cyanide
592−01−8
30
Carbon Disulfide
75−15−0
200
Chloral
75−87−6
2
Chlorine (free)
0.4
2−Chloro−1,3−butadiene
126−99−8
3
Chromium III
16065−83−1
1000
Copper Cyanide
544−92−3
5
Cresols
1319−77−3
50
Cumene
98−82−8
1
Cyanide (free)
57−12−15
20
Cyanogen
460−19−5
30
Cyanogen Bromide
506−68−3
80
Di−n−butyl Phthalate
84−74−2
100
o−Dichlorobenzene
95−50−1
10
p−Dichlorobenzene
106−46−7
10
Dichlorodifluoromethane
75−71−8
200
2,4−Dichlorophenol
120−83−2
3
Diethyl Phthalate
84−66−2
800
Dimethoate
60−51−5
0.8
2,4−Dinitrophenol
51−28−5
2
Dinoseb
88−85−7
0.9
Diphenylamine
122−39−4
20
Endosulfan
115−29−1
0.05
Endrin
72−20−8
0.3
Fluorine
7782−41−4
50
Formic Acid
64−18−6
2000
Glycidyaldehyde
765−34−4
0.3
Hexachlorocyclopentadiene
77−47−4
5
Hexachlorophene
70−30−4
0.3
Hydrocyanic Acid
74−90−8
20
Hydrogen Chloride
7647−01−1
7
Hydrogen Sulfide
7783−06−4
3
Isobutyl Alcohol
78−83−1
300
Lead
7439−92−1
0.09
Maleic Anyhdride Anhydride
108−31−6
100
Mercury
7439−97−6
0.3
Methacrylonitrile
126−98−7
0.1
Methomyl
16752−77−5
20
Methoxychlor
72−43−5
50
Methyl Chlorocarbonate
79−22−1
1000
Methyl Ethyl Ketone
78−93−3
80
Methyl Parathion
298−00−0
0.3
Nickel Cyanide
557−19−7
20
Nitric Oxide
10102−43−9
100
Nitrobenzene
98−95−3
0.8
Pentachlorobenzene
608−93−5
0.8
Pentachlorophenol
87−86−5
30
Phenol
108−95−2
30
M−Phenylenediamine
108−45−2
5
Phenylmercuric Acetate
62−38−4
0.075
Phosphine
7803−51−2
0.3
Phthalic Anhydride
85−44−9
2000
Potassium Cyanide
151−50−8
50
Potassium Silver Cyanide
506−61−6
200
Pyridine
110−86−1
1
Selenious Acid
7783−60−8
3
Selenourea
630−10−4
5
Silver
7440−22−4
3
Silver Cyanide
506−64−9
100
Sodium Cyanide
143−33−9
30
Strychnine
57−24−9
0.3
1,2,4,5−Tetrachlorobenzene
95−94−3
0.3
2,3,4,6−Tetrachlorophenol
58−90−2
30
Tetraethyl Lead
78−00−2
0.0001
Tetrahydrofuran
109−99−9
10
Thallic Oxide
1314−32−5
0.3
Thallium
7440−28−0
0.5
Thallium (I) Acetate
563−68−8
0.5
Thallium (I) Carbonate
6533−73−9
0.3
Thallium (I) Chloride
7791−12−0
0.3
Thallium (I) Nitrate
10102−45−1
0.5
Thallium Selenite
12039−52−0
0.5
Thallium (I) Sulfate
7446−18−6
0.075
Thiram
137−26−8
5
Toluene
108−88−3
300
1,2,4−Trichlorobenzene
120−82−1
20
Trichloromonofluoromethane
75−69−4
300
2.,4.,5−Trichlorophenol
95−95−4
100
Vanadium Pentoxide
1314−62−1
20
Warfarin
81−81−2
0.3
Xylenes
1330−20−7
80
Zinc Cyanide
557−21−1
50
Zinc Phosphide
1314−84−7
0.3
*The RAC for other ch. NR 661 Appendix VIII constituents not listed herein or in Appendix V is 0.1 ug/m3.
Section 88.   NR 666 Appendix V Table is amended to read:
Chapter NR 666
APPENDIX V
RISK SPECIFIC DOSES (10−5)
Constituent
CAS No.
Unit risk (m3/ug)
RsD (ug/m3)
Acrylamide
79−06−1
1.3E−03
7.7E−03
Acrylonitrile
107−13−1
6.8E−05
1.5E−01
Aldrin
309−00−2
4.9E−03
2.0E−03
Aniline
62−53−3
7.4E−06
1.4E+00
Arsenic
7440−38−2
4.3E−03
2.3E−03
Benz(a)anthracene
56−55−3
8.9E−04
1.1E−02
Benzene
71−43−2
8.3E−06
1.2E+00
Benzidine
92−87−5
6.7E−02
1.5E−04
Benzo(a)pyrene
50−32−8
3.3E−03
3.0E−03
Beryllium
7440−41−7
2.4E−03
4.2E−03
Bis(2−chloroethyl)ether
111−44−4
3.3E−04
3.0E−02
Bis(chloromethyl)ether
542−88−1
6.2E−02
1.6E−04
Bis(2−ethylhexyl)−phthalate
117−81−7
2.4E−07
4.2E+01
1,3−Butadiene
106−99−0
2.8E−04
3.6E−02
Cadmium
7440−43−9
1.8E−03
5.6E−03
Carbon Tetrachloride
56−23−5
1.5E−05
6.7E−01
Chlordane
57−74−9
3.7E−04
2.7E−02
Chloroform
67−66−3
2.3E−05
4.3E−01
Chloromethane
74−87−3
3.6E−06
2.8E+00
Chromium VI
7440−47−3
1.2E−02
8.3E−04
DDT
50−29−3
9.7E−05
1.0E−01
Dibenz(a,h)anthracene
53−70−3
1.4E−02
7.1E−04
1,2−Dibromo−3−chloropropane
96−12−8
6.3E−03
1.6E−03
1,2−Dibromoethane
106−93−4
2.2E−04
4.5E−02
1,1−Dichloroethane
75−34−3
2.6E−05
3.8E−01
1,2−Dichloroethane
107−06−2
2.6E−05
3.8E−01
1,1−Dichloroethylene
75−35−4
5.0E−05
2.0E−01
1,3−Dichloropropene
542−75−6
3.5E−01
2.9E−05
Dieldrin
60−57−1
4.6E−03
2.2E−03
Diethylstilbestrol
56−53−1
1.4E−01
7.1E−05
Dimethylnitrosamine
62−75−9
1.4E−02
7.1E−04
2,4−Dinitrotoluene
121−14−2
8.8E−05
1.1E−01
1,2−Diphenylhydrazine
122−66−7
2.2E−04
4.5E−02
1,4−Dioxane
123−91−1
1.4E−06
7.1E+00
Epichlorohydrin
106−89−8
1.2E−06
8.3E+00
Ethylene Oxide
75−21−8
1.0E−04
1.0E−01
Ethylene Dibromide
106−93−4
2.2E−04
4.5E−02
Formaldehyde
50−00−0
1.3E−05
7.7E−01
Heptachlor
76−44−8
1.3E−03
7.7E−03
Heptachlor Epoxide
1024−57−3
2.6E−03
3.8E−03
Hexachlorobenzene
118−74−1
4.9E−04
2.0E−02
Hexachlorobutadiene
87−68−3
2.0E−05
5.0E−01
Alpha−hexachloro−cyclohexane
319−84−6
1.8E−03
5.6E−03
Beta−hexachloro−cyclohexane
319−85−7
5.3E−04
1.9E−02
Gamma−hexachloro−cyclohexane
58−89−9
3.8E−04
2.6E−02
Hexachlorocyclo−hexane, Technical
5.1E−04
2.0E−02
Hexachlorodibenxo−p−dioxin Hexachlorodibenzo-p-dioxin (1,2 Mixture)
1.3E+0
7.7E−06
Hexachloroethane
67−72−1
4.0E−06
2.5E+00
Hydrazine
302−01−2
2.9E−03
3.4E−03
Hydrazine Sulfate
302−01−2
2.9E−03
3.4E−03
3−Methylcholanthrene
56−49−5
2.7E−03
3.7E−03
Methyl Hydrazine
60−34−4
3.1E−04
3.2E−02
Methylene Chloride
75−09−2
4.1E−06
2.4E+00
4,4’−Methylene−bis−2−chloroaniline
101−14−4
4.7E−05
2.1E−01
Nickel
7440−02−0
2.4E−04
4.2E−02
Nickel Refinery Dust
7440−02−0
2.4E−04
4.2E−02
Nickel Subsulfide
12035−72−2
4.8E−04
2.1E−02
2−Nitropropane
79−46−9
2.7E−02
3.7E−04
N−Nitroso−n−butylamine
924−16−3
1.6E−03
6.3E−03
N−Nitroso−n−methylurea
684−93−5
8.6E−02
1.2E−04
N−Nitrosodiethylamine
55−18−5
4.3E−02
2.3E−04
N−Nitrosopyrrolidine
930−55−2
6.1E−04
1.6E−02
Pentachloronitrobenzene
82−68−8
7.3E−05
1.4E−01
PCBs
1336−36−3
1.2E−03
8.3E−03
Pronamide
23950−58−5
4.6E−06
2.2E+00
Reserpine
50−55−5
3.0E−03
3.3E−03
2,3,7,8−Tetrachloro−dibenzo−p−dioxin
1746−01−6
4.5E+01
2.2E−07
1,1,2,2−Tetrachloroethane
79−34−5
5.8E−05
1.7E−01
Tetrachloroethylene
127−18−4
4.8E−07
2.1E+01
Thiourea
62−56−6
5.5E−04
1.8E−02
1,1,2−Trichloroethane
79−00−5
1.6E−05
6.3E−01
Trichloroethylene
79−01−6
1.3E−06
7.7E+00
2,4,6−Trichlorophenol
88−06−2
5.7E−06
1.8E+00
Toxaphene
8001−35−2
3.2E−04
3.1E−02
Vinyl Chloride
75−01−4
7.1E−06
1.4E+00
_Hlk153534558Section 89.   NR 668.04 (1) (c) (intro.) is amended to read:
NR 668.04 (1) (c) The impoundment meets the design requirements of under s. NR 664.0221 (3) or 665.0221 (1), regardless that the unit may not be new, expanded, or a replacement, and the impoundment is in compliance with applicable groundwater monitoring requirements of ch. under ch. NR 664 or 665 unless one of the following conditions are is met:
Section 90.   NR 668.07 (1) (d) Table row 8., (3) (b), and (4) (b) are amended to read:
NR 668.07 (1) (d)
Generator Paperwork Requirements Table
8. For contaminated soil subject to LDRs as provided in under s. NR 668.49 (1), the constituents subject to treatment as described in under s. NR 668.49 (4), and the following statement: This contaminated soil [does/does not] contain listed hazardous waste and [does/does not] exhibit a characteristic of hazardous waste and [is subject to/complies with with] the soil treatment standards as provided by under s. NR 668.49 (3) or the universal treatment standards
✓
✓
(3) (b) Test the waste, or an extract of the waste or treatment residue developed using test method 1311 (the Toxicity Characteristic Leaching Procedure), described in “Test Methods for Evaluating Solid Waste, Physical/Chemical Methods", EPA SW-846, incorporated by reference in under s. NR 660.11), to assure that the wastes or treatment residues are in compliance with the applicable treatment standards set forth in under subch. D. This testing shall be performed according to the frequency specified in the facility's waste analysis plan as required by s. NR 664.0013 or 665.0013.
Down
Loading...
Loading...
Links to Admin. Code and Statutes in this Register are to current versions, which may not be the version that was referred to in the original published document.